心脉隆注射液对急性心肌梗死范围的影响及其临床意义

目的探讨心脉隆注射液对急性心肌梗死范围的影响及其临床意义。方法 112例患者随机分为两组,试验组59例,对照组53例。两组均按急性心肌梗死治疗指南进行治疗,对照组患者接受抗血小板、抗凝、降脂、降压、扩张冠状动脉等方面治疗,试验组在对照组治疗基础上加用心脉隆注射液静脉滴注,每天2次,连续使用5 d。比较两组患者的心肌梗死范围及预后。结果两组患者入院时心肌梗死范围比较,差异无统计学意义（P〉0.05）;第5天试验组心肌梗死范围明显低于对照组（P〈0.01）;两组梗死范围回缩率比较,差异有统计学意义（P〈0.01）。试验组并发症总发生率（12%）明显低于对照组（28%）（P〈0.05）;试验组心力衰竭4例（7%）、梗死后心绞痛2例（3%）,与对照组分项比较,差异有统计学意义（P〈0.05）。结论心脉隆注射液能有效缩小急性心肌梗死范围,有效减少住院期间心脏事件的发生。

Impacts of Xinmailong Injection on Acute Myocardial Infarction Range and its Clinical Significance

Objective To explore the impacts of xinmailong injection on acute myocardial infarction range and its clinical significance.Methods 112 cases were randomized into two groups,named trial group(59 cases)and control group(53 cases).The cases in either group were treated according to the guideline for acute myocardial infarction.In control group,the cases received the treatments for antiplatelet,anticoagulation,lipid-lowering,anti-hypertension,dilating coronary artery,etc.In trial group,on the basis of the trea...